| Kimberly Kristin Duried Kassab, | |
|
738 Chandelle Rd, Castle Rock, CO 80104-7730 | |
| (720) 471-8079 | |
| Not Available |
| Full Name | Kimberly Kristin Duried Kassab |
|---|---|
| Gender | Female |
| Speciality | Student In An Organized Health Care Education/training Program |
| Location | 738 Chandelle Rd, Castle Rock, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346019742 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Kimberly Kristin Duried Kassab, 738 Chandelle Rd, Castle Rock, CO 80104-7730 Ph: (720) 471-8079 | Kimberly Kristin Duried Kassab, 738 Chandelle Rd, Castle Rock, CO 80104-7730 Ph: (720) 471-8079 |
News Archive
Japanese researchers reveal an association between elevated FIB-4 index 24 weeks after the initiation of nucleos(t)ide analogue therapy and the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
A University of Illinois Chicago research study on how to improve care for heart disease patients struggling with hopelessness has been supplemented by the National Institutes of Health, or NIH, to determine whether the study intervention called "Heart Up!" limits the negative impact of COVID-19 shelter-in-place and physical distancing measures on health outcomes.
The proper role of health insurance should be to finance necessary and expensive medical services without the patient incurring devastating financial consequences. Over the last decade, however, Americans have come to expect their health insurance to subsidize the consumption of all medical care. ... This shift in expectation has meant that health insurance stands out as entirely different from all other types of insurance. Ask yourself: Would you use automobile insurance to buy gasoline? Would you use homeowner insurance to finance painting your house? This wrongheaded view has played an important role in contributing to rapidly rising health care costs (George P. Shultz, Scott W. Atlas and John F. Cogan, 1/5).
Abiraterone acetate (abiraterone for short, trade name: Zytiga) has been approved in Germany since December 2012 for men with metastatic prostate cancer that is not responsive to hormone blockade, who only have mild symptoms or so far none at all, and in whom chemotherapy is not yet indicated.
A research team led by scientists at the Krembil Research Institute in Toronto has identified a new neuroprotective factor that has the potential to help people suffering from the common blinding disease glaucoma.
› Verified 1 days ago